Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ascal not safer than aspirin

01.02.2008
Changing prescription of low-dose aspirin into calcium carbasalate (brand name: Ascal) to prevent peptic ulcerations is not useful. Peptic ulcers are evenly distributed among users of calcium carbasalate and aspirin, for secondary prevention of myocardial infarction.

These numbers are presented in a scientific publication by researchers of the Radboud University Nijmegen Medical Centre and the Erasmus Medical Centre Rotterdam (The Netherlands), online first in Clinical Gastroenterology and Hepatology, the official clinical journal of the American Gastroenterology Association (AGA).

Side effects
More than 1.1 million patients are prescribed low-dose aspirin for platelet aggregation inhibition in The Netherlands (GIP database, CVZ 2006). However, a significant number of patients on aspirin experience side effects, like bloating, nausea or even peptic ulcers. These effects can be contributed to both local and systemic pathways: 1) poor disintegration of aspirin may cause drug concentration to be higher in certain parts of the stomach leading to a direct irritating effect; 2) aspirin decreases the production of prostaglandins, that are required for gastric mucosal wall integrity. Consequently, aspirin can change the gastric environment into more sensitive for development of peptic ulcerations.
Comparison
Calcium carbasalate is a salt formulation of aspirin, and therefore more soluble and less harmful to the stomach. In order to prevent local toxic effects, this seemed a useful alternative for patients that experience or have a higher risk for side effects on aspirin. However, strict comparison in a study supervised by Martijn van Oijen MSc of the department of Gastroenterology and Hepatology of the Radboud University Nijmegen Medical Centre, indicate that cardiovascular patients using calcium carbasalate develop peptic ulcers to the same amount as on aspirin.
For this purpose the Dutch IPCI (Integrated Primary Care Information) database was studied: a general practice research database containing data from approximately 500,000 electronic patient records of a group of about 150 general practitioners. All patients using low-dose aspirin (11,891) or low-dose calcium carbasalate (7,928) were selected. In these patients 115 peptic ulcers were found. After adjustment for the duration of medication use and risk factors, the risk for peptic ulcer was similar in the group using calcium carbasalate compared with aspirin.

This implicates that peptic ulcers seem to be related to systemic effects on gastric mucosal wall integrity rather than to local irritating effects in patients using low-dose aspirin.

Limitations
The researchers are aware of the limitations of the observational study. Because of its protective image, physicians may prescribe calcium carbasalate preferably to patients with known gastrointestinal complaints, which may modify the results of the study. To overcome this issue, the usage of acid suppressive drugs in the study population was analyzed and found not different between users of calcium carbasalate and aspirin.

Joke Groeneveld | alfa
Further information:
http://www.umcn.nl

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>